March ANDA Approvals
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
Full and tentative approvals of generic drugs.
You may also be interested in...
Medtech SMEs See Opportunities In UK Budget Of Few Surprises
Schemes and funding to support growth in the life sciences and medtech sectors featured in the UK government’s spring budget on 3 March.
Entries Open For The Global Generics & Biosimilars Awards 2021
Entries are now open for the Global Generics & Biosimilars Awards 2021, which will take place in Milan, Italy on 10 November.
Bharat Biotech Gets Shot In Arm With 81% Efficacy For COVID-19 Vaccine
Bharat Biotech’s COVID-19 vaccine has shown 80.6% efficacy in interim data from Phase III clinical trials, slightly better than the 79.3% reported by Sinopharm and significantly higher than Sinovac’s 50.6% for their vaccines based on similar technology. Supply deals are already on the way, with Brazil having signed up for 200 million doses.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: